MENU
+Compare
NPCE
Stock ticker: NASDAQ
AS OF
Dec 24 closing price
Price
$16.19
Change
-$0.16 (-0.98%)
Capitalization
539.25M

NPCE Neuropace Forecast, Technical & Fundamental Analysis

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures... Show more

NPCE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NPCE with price predictions
Dec 24, 2025

NPCE's RSI Indicator recovers from overbought zone

The 10-day RSI Oscillator for NPCE moved out of overbought territory on December 05, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 instances where the indicator moved out of the overbought zone. In of the 27 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 52 cases where NPCE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on December 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NPCE as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NPCE turned negative on December 09, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NPCE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NPCE broke above its upper Bollinger Band on November 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The 50-day moving average for NPCE moved above the 200-day moving average on November 25, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NPCE advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 195 cases where NPCE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NPCE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (29.155) is normal, around the industry mean (63.841). P/E Ratio (0.000) is within average values for comparable stocks, (37.253). NPCE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.634). NPCE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (5.435) is also within normal values, averaging (36.935).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NPCE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
NPCE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NPCE is expected to report earnings to rise 66.91% to -18 cents per share on March 10

Neuropace NPCE Stock Earnings Reports
Q4'25
Est.
$-0.18
Q3'25
Beat
by $0.09
Q2'25
Missed
by $0.04
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.07
The last earnings report on November 04 showed earnings per share of -10 cents, beating the estimate of -20 cents. With 58.77K shares outstanding, the current market capitalization sits at 539.25M.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
455 N. Bernardo Avenue
Phone
+1 650 237-2700
Employees
167
Web
https://www.neuropace.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GUXPX5.530.02
+0.36%
Gabelli Utilities C
OAYBX39.420.11
+0.28%
Oakmark Equity and Income Advisor
MGINX11.410.01
+0.09%
DWS Global Macro Inst
BCSSX25.470.01
+0.04%
Brown Capital Mgmt Small Co Instl
RPNIX12.24N/A
N/A
Riverpark/Next Century Gr Inst

NPCE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NPCE has been loosely correlated with STVN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NPCE jumps, then STVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NPCE
1D Price
Change %
NPCE100%
-1.27%
STVN - NPCE
37%
Loosely correlated
+1.51%
ESTA - NPCE
31%
Poorly correlated
-0.63%
SMTI - NPCE
30%
Poorly correlated
-2.12%
NTRA - NPCE
29%
Poorly correlated
-0.07%
GH - NPCE
29%
Poorly correlated
+1.14%
More

Groups containing NPCE

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NPCE
1D Price
Change %
NPCE100%
-1.27%
Medical/Nursing Services
industry (213 stocks)
32%
Poorly correlated
+0.17%
Health Services
industry (404 stocks)
-1%
Poorly correlated
+0.20%